First National Bank of Omaha Has $809,000 Stake in Addus HomeCare Co. (NASDAQ:ADUS)

First National Bank of Omaha decreased its position in Addus HomeCare Co. (NASDAQ:ADUS) by 3.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,085 shares of the company’s stock after selling 210 shares during the quarter. First National Bank of Omaha’s holdings in Addus HomeCare were worth $809,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ADUS. Ellsworth Advisors LLC bought a new stake in shares of Addus HomeCare in the second quarter valued at approximately $598,000. SG Americas Securities LLC bought a new stake in shares of Addus HomeCare in the second quarter valued at approximately $842,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Addus HomeCare in the third quarter valued at approximately $1,622,000. Dimensional Fund Advisors LP boosted its stake in shares of Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after buying an additional 5,421 shares during the period. Finally, Argent Capital Management LLC boosted its stake in shares of Addus HomeCare by 51.5% in the second quarter. Argent Capital Management LLC now owns 37,310 shares of the company’s stock valued at $4,332,000 after buying an additional 12,685 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

Shares of ADUS opened at $120.74 on Monday. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The stock has a market capitalization of $2.19 billion, a price-to-earnings ratio of 27.63, a PEG ratio of 2.16 and a beta of 1.01. The stock has a fifty day moving average of $126.26 and a 200-day moving average of $124.16.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.03 earnings per share. As a group, equities analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on ADUS shares. StockNews.com cut Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Tuesday, December 3rd. Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Stephens upped their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. KeyCorp started coverage on Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. Finally, Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Insiders Place Their Bets

In other news, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This represents a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.